Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
from TechCrunch https://ift.tt/srgKkpF
Wednesday, October 14, 2026
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment